The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Antipsychotic Drugs, Neurotransmitters, and Schizophrenia
Abstract
Inhibition of central dopamine functions appears to be a common basic property of antipsychotic drugs. The mesolimbic and nigrostriatal portions of the dopaminergic system are probably the main targets for the mental and the extrapyramidal actions, respectively, of these drugs. The fact that dopaminergic hyperfunction induced by amphetamines or dopa may lead to a disturbance mimicking paranoid schizophrenia lends further support for a key role of dopamine in mental functions. Although a primary disturbance in dopamine function in schizophrenia cannot be ruled out, the intimate relationship between dopaminergic and other neuronal systems must be emphasized. The possible involvement of other amine, amino acid, or peptide transmitters in schizophrenia cannot be disregarded.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stereotaxic mapping of the monoamine pathways in the rat brain
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb10998.x · Cited by 3,819
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Self-citationDOPAMINERGIC NEURONS: EFFECT OF ANTIPSYCHOTIC DRUGS AND AMPHETAMINE ON SINGLE CELL ACTIVITY
BUNNEY, B. S., WALTERS, J. R., ROTH, R. H., & AGHAJANIAN, G. K. (1973) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)29539-8 · Cited by 1,283
Receptor activity and turnover of dopamine and noradrenaline after neuroleptics
Andén, N.-E., Butcher, S. G., Corrodi, H., Fuxe, K., & Ungerstedt, U. (1970) · European Journal of Pharmacology · doi:10.1016/0014-2999(70)90006-3 · Cited by 1,026
Psychopharmacology. A Review of Progress, 1957-1967
Burger, A. (1969) · Journal of Medicinal Chemistry · doi:10.1021/jm00305a903 · Cited by 891
The Dopamine Hypothesis of Schizophrenia: A Review*
Meltzer, H. Y., & Stahl, S. M. (1976) · Schizophrenia Bulletin · doi:10.1093/schbul/2.1.19 · Cited by 883
Groves, P. M., Wilson, C. J., Young, S. J., & Rebec, G. V. (1975) · Science · doi:10.1126/science.242074 · Cited by 642
Aghajanian, G. K., & Bunney, B. S. (1977) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00508803 · Cited by 547
Dopamine in dendrites of substantia nigra neurons: suggestions for a role in dendritic terminals
Bjo¨rklund, A., & Lindvall, O. (1975) · Brain Research · doi:10.1016/0006-8993(75)90849-5 · Cited by 483
Cited by
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Glutamate receptor dysfunction and schizophrenia
Olney, J. W. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950240016004 · Cited by 1,685
Dopamine receptors and the dopamine hypothesis of schizophrenia
Seeman, P. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880
Serotonin receptors : their key role in drugs to treat schizophrenia
Meltzer, H. Y., Li, Z., Kaneda, Y., & Ichikawa, J. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.09.010 · Cited by 775
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons
White, F. J., & Wang, R. Y. (1983) · Science · doi:10.1126/science.6136093 · Cited by 588
Freedman, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035458 · Cited by 587
The Glutamatergic Dysfunction Hypothesis for Schizophrenia
Coyle, J. T. (1996) · Harvard Review of Psychiatry · doi:10.3109/10673229609017192 · Cited by 568
Farde, L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810150013003 · Cited by 530
Nordström, A.-L., Farde, L., Wiesel, F.-A., Forslund, K., Pauli, S., Halldin, C., & Uppfeldt, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90288-o · Cited by 527
Cools, R., Barker, R. A., Sahakian, B. J., & Robbins, T. W. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(03)00117-9 · Cited by 516
Comparative anatomy of the histaminergic and other aminergic systems in zebrafish (Danio rerio)
Kaslin, J., & Panula, P. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1390 · Cited by 403
Moghaddam, B. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01362-2 · Cited by 392
Schizophrenia: A Subcortical Neurotransmitter Imbalance Syndrome?
Carlsson, M., & Carlsson, A. (1990) · Schizophrenia Bulletin · doi:10.1093/schbul/16.3.425 · Cited by 341
Self-citationD1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics
Farde, L., Wiesel, F. A., Nordstr�m, A. L., & Sedvall, G. (1989) · Psychopharmacology · doi:10.1007/bf00442555 · Cited by 325
Pathway-Specific Dopamine Abnormalities in Schizophrenia
Weinstein, J. J., Chohan, M. O., Slifstein, M., Kegeles, L. S., Moore, H., & Abi-Dargham, A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.03.2104 · Cited by 297
Povlsen, U. J., Norrng, U., Fog, R., & Gerlach, J. (1985) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1985.tb01268.x · Cited by 278
Clozapine: A Review of its Pharmacological Properties, and Therapeutic Use in Schizophrenia
Fitton, A., & Heel, R. C. (1990) · Drugs · doi:10.2165/00003495-199040050-00007 · Cited by 278
Comings, D. E., Wu, S., Chiu, C., Ring, R. H., Gade, R., Ahn, C., MacMurray, J. P., Dietz, G., & Muhleman, D. (1996) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19960531)67:3<264::aid-ajmg4>3.0.co;2-n · Cited by 270
Dazzan, P., Morgan, K. D., Orr, K., Hutchinson, G., Chitnis, X., Suckling, J., Fearon, P., McGuire, P. K., Mallett, R. M., Jones, P. B., et al. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300603 · Cited by 259
Weiner, D. M., Meltzer, H. Y., Veinbergs, I., Donohue, E. M., Spalding, T. A., Smith, T. T., Mohell, N., Harvey, S. C., Lameh, J., Nash, N., et al. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1940-5 · Cited by 253
Commissiong, J. W. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90484-8 · Cited by 252
Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters
Engström, G., Alling, C., Blennow, K., Regnéll, G., & Träskman-Bendz, L. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00016-4 · Cited by 157
Kuepper, R., Morrison, P. D., van Os, J., Murray, R. M., Kenis, G., & Henquet, C. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2010.05.031 · Cited by 116
Moseley, P., Fernyhough, C., & Ellison, A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.10.001 · Cited by 113
Dopamine neurons in the ventral tegmental area fire faster in adolescent rats than in adults
McCutcheon, J. E., Conrad, K. L., Carr, S. B., Ford, K. A., McGehee, D. S., & Marinelli, M. (2012) · Journal of Neurophysiology · doi:10.1152/jn.00077.2012 · Cited by 106
“Adolescence is also a time that sees the onset or exacerbation of many psychiatric disorders (Paus et al. 2008), which have been associated with elevated dopaminergic transmission (Carlsson 1978; Diehl and Gershon 1992; Wise and Rompre 1989).”
BackgroundAssociation between a promoter variant in the monoamine oxidase A gene and schizophrenia
Jönsson, E. G., Norton, N., Forslund, K., Mattila-Evenden, M., Rylander, G., Åsberg, M., Owen, M. J., & Sedvall, G. C. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00224-4 · Cited by 57
Rebec, G. V. (1998) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1998.tb03614.x · Cited by 51
van Berckel, B. N. M., Kegeles, L. S., Waterhouse, R., Guo, N., Hwang, D.-R., Huang, Y., Narendran, R., Van Heertum, R., & Laruelle, M. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300902 · Cited by 43
Metadata
- Authors
- CARLSSON, A.
- Venue
- American Journal of Psychiatry
- Published
- 1978-02
- Volume
- 135
- Issue
- 2
- Pages
- 164-173
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2106926455
- Cited by
- 498
- References
- 45
- FWCI
- 25.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.